134 related articles for article (PubMed ID: 36332115)
1. Extraordinary Case: Unique Presentation of an Aggressive Epstein-Barr Virus-Positive Mucocutaneous Ulcer.
Miyashiro D; Nico MMS; Ang PL; Coelho Siqueira SA; Pereira J; Sanches JA; Lourenço SV
Am J Dermatopathol; 2022 Dec; 44(12):948-951. PubMed ID: 36332115
[TBL] [Abstract][Full Text] [Related]
2. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
Beltran BE; Castillo JJ; Salas R; Quiñones P; Morales D; Cotrina E; Miranda RN; Sotomayor EM
Leuk Lymphoma; 2011 Jan; 52(1):153-6. PubMed ID: 21219127
[No Abstract] [Full Text] [Related]
4. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
Kuriyama T; Kawano N; Yamashita K; Ueda A
J Clin Exp Hematop; 2014; 54(2):149-53. PubMed ID: 25318948
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
Yoon SE; Kim SJ; Yoon DH; Koh Y; Mun YC; Do YR; Choi YS; Yang DH; Kim MK; Lee GW; Suh C; Ko YH; Kim WS
Ann Hematol; 2020 Jun; 99(6):1283-1291. PubMed ID: 32333154
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
[TBL] [Abstract][Full Text] [Related]
7. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
[TBL] [Abstract][Full Text] [Related]
8. An aggressive case of EBV-positive mucocutaneous ulcer in the female genital area; successful response to rituximab.
Rodríguez-Lago L; Peñate Y; Marrero-Quintana MT; Andújar-Sánchez M; Rodríguez-López J
Dermatol Ther; 2022 Jul; 35(7):e15527. PubMed ID: 35441767
[No Abstract] [Full Text] [Related]
9. HIV-associated anorectal Epstein-Barr virus-positive mucocutaneous ulcer successfully treated with liposomal doxorubicin and rituximab.
Whooley PD; Dorer RK; Kumar AS; Aboulafia DM
AIDS; 2019 Apr; 33(5):929-930. PubMed ID: 30882496
[No Abstract] [Full Text] [Related]
10. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial.
Melani C; Dowdell K; Pittaluga S; Dunleavy K; Roschewski M; Song JY; Calattini S; Kawada JI; Price DA; Chattopadhyay PK; Roederer M; Lucas AN; Steinberg SM; Jaffe ES; Cohen JI; Wilson WH
Lancet Haematol; 2023 May; 10(5):e346-e358. PubMed ID: 37011643
[TBL] [Abstract][Full Text] [Related]
12. The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.
Bosman G; Langemeijer SM; Hebeda KM; Raemaekers JM; Pickkers P; van der Velden WJ
Neth J Med; 2009 Sep; 67(8):364-5. PubMed ID: 19767670
[No Abstract] [Full Text] [Related]
13. Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
Xu L; Liu X; Wang Y; Wang Y; Chu X; Chen L
Medicine (Baltimore); 2022 Mar; 101(9):e28943. PubMed ID: 35244052
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.
Johnston A; Salles G; Espinouse D; Felman P; André P; Berger F; Coiffier B
Clin Lymphoma Myeloma; 2008 Dec; 8(6):356-8. PubMed ID: 19064401
[TBL] [Abstract][Full Text] [Related]
16. Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient.
Navarro JT; Ribera JM; Juncà J; Millá F
Hum Pathol; 2003 Jun; 34(6):630. PubMed ID: 12827623
[No Abstract] [Full Text] [Related]
17. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
18. Head and neck Epstein-Barr virus mucocutaneous ulcer: Case report and literature review.
Au JK; Said JW; Sepahdari AR; St John MA
Laryngoscope; 2016 Nov; 126(11):2500-2504. PubMed ID: 27113560
[TBL] [Abstract][Full Text] [Related]
19. Oral Epstein-Barr virus-positive mucocutaneous ulcer: gingival presentation of a benign lymphoproliferative lesion.
Li DTS; Lo AWI; Su YX
Int J Oral Maxillofac Surg; 2020 Oct; 49(10):1351-1354. PubMed ID: 31982237
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]